MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    DPPX Autoimmune Encephalitis Associated with Severe Multifocal Dystonia.

    E. Roddy, E. Gentry, P. Hedera, V. Holiday, D. Robertson (LOUISVILLE, USA)

    Objective: To describe a novel motor phenomenology in an individual diagnosed with anti-DPPX encephalitis at our institution and to compare it with previously known phenotypic…
  • 2024 International Congress

    Therapeutic challenges of long-standing chelator therapy in Wilson’s Disease

    C. Guedes Vaz, H. Pessegueiro, J. Castro Ferreira, J. Gandara, V. Dionísio Lopes, E. Silva, S. Ferreira, C. Pereira, D. Valadares, L. Maia, J. Presa, A. Pinto, A. Costa, C. Rolanda, C. Agostinho, I. Gonçalves, P. Peixoto, R. Costa, S. Lopes, M. Magalhães (Porto, Portugal)

    Objective: To determine the frequency of side effects of long-term copper chelation therapy in Wilson’s disease (WD). Background: WD is a neurometabolic autosomal recessive disorder…
  • 2024 International Congress

    Artificial intelligence: a potential predictor of GBA1-mutated genotype in Parkinson’s Disease patients?

    G. Di Rauso, A. Ghibellini, S. Grisanti, F. Cavallieri, V. Fioravanti, E. Monfrini, G. Toschi, G. Portaro, J. Rossi, R. Sabadini, L. Gherardini, C. Lucchi, G. Biagini, L. Bononi, M. Gabbrielli, A. Di Fonzo, F. Valzania (Reggio Emilia, Italy)

    Objective: To assess whether artificial intelligence could predict GBA1-mutated genotype in Parkinson’s Disease (GBA1-PD) patients according to the different impact of significant clinical features. Background:…
  • 2024 International Congress

    SLC39A8-CDG with manganese deficiency in an adult individual: a case report

    D. Cury Portela, T. Gonçalves Guimarães, G. Sousa Noleto, L. Sousa Araújo, I. Paula, S. Morais, V. Santana Vasconcelos (Teresina, Brazil)

    Objective: To report the case of an adult male with SLC39A8-CDG and evaluate the effects of manganese supplementation on clinical evolution of the patient. Background:…
  • 2023 International Congress

    A benign course of Parkinson’s disease associated with different mutations in the glucocerebrosidase gene – a case series

    G. Yahalom, A. Faust-Socher, M. Cohen, Y. Schechter, M. Becker-Cohen, R. Eichel, S. Revel-Vilk, A. Zimran (Jerusalem, Israel)

    Objective: Herein we describe 5 cases of GBA-related PD patients with a markedly benign course. Background: Subjects carrying mutations in the GBA1 gene, whether in…
  • 2023 International Congress

    GBA haplotypes and age at onset of Parkinson’s disease in the Asian population

    C. Li, R. Ou, Y. Hou, Q. Wei, L. Zhang, K. Liu, J. Lin, X. Chen, W. Song, B. Zhao, Y. Wu, H. Shang (Chengdu, China)

    Objective: To explore the involvement of GBA haplotypes in age at onset of Parkinson's disease in the Asian population. Background: GBA is an important risk…
  • 2023 International Congress

    The effect of intranasal insulin administration on motor and non-motor symptoms in Parkinson’s disease patients; a randomized double-blinded placebo-controlled clinical trial

    M. Salari, N. Valian, L. Mohaghegh Shalmani, R. Rashedi, H. Ashourizadeh, L. Dargahi (Tehran, Islamic Republic of Iran)

    Objective: To evaluating the effect of intranasal insulin administration on motor and non-motor symptoms in Parkinson’s disease patients; a randomized double-blinded placebo-controlled clinical trial Background:…
  • 2023 International Congress

    Association between lifestyle and environmental factors with disease severity and age at onset in multi-ethnic Malaysian Parkinson’s disease patients

    JP. Schee, HC. Ting, ZL. Loo, AMF. Dy Closas, TS. Toh, JW. Hor, YW. Tay, JL. Lim, LC. Lit, AH. Tan, SY. Lim (Kuala Lumpur, Malaysia)

    Objective: We explored the association between self-reported exposure to caffeine, smoking, and environmental toxins (pesticides, chemical solvents, heavy metals, other chemicals, and fumes) with Aao…
  • 2023 International Congress

    Asymptomatic Gaucher disease presented as Parkinsonism in 61 years old patient.

    E. Basha, E. Ranxha, J. Tana (Tirana, Albania)

    Objective: Gaucher disease is an inherited disease caused by a mutation in the glucocerebrosidase gene, causing visceral, hematologic, and skeletal involvement. [1] [2] We report…
  • 2023 International Congress

    Analysis of the network of genes related to Parkinson’s and identification of key proteins

    H. Ghapani, D. Morshedi, S. Parsafar, F. Aliakbari (Tehran, Islamic Republic of Iran)

    Objective: Parkinson's disease (PD) is one of the increasing age-related diseases with no definite treatment. PD is considered as a disorder with genetic and non-genetic…
  • « Previous Page
  • 1
  • …
  • 179
  • 180
  • 181
  • 182
  • 183
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #25179 (not found)
  • Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Decision-making process for opicapone’s bedtime regimen
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley